AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.
about
Diabetes mellitus and renal failure: Prevention and managementHigh Glucose Promotes CD36 Expression by Upregulating Peroxisome Proliferator-Activated Receptor γ Levels to Exacerbate Lipid Deposition in Renal Tubular Cells.Association between angiotensin II receptor type 1 A1166C polymorphism and chronic kidney disease.
P2860
AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.
@en
AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.
@nl
type
label
AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.
@en
AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.
@nl
prefLabel
AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.
@en
AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.
@nl
P2093
P2860
P50
P356
P1476
AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy
@en
P2093
Mahmood Vessal
Sonia Amiri
Ziba Rahimi
Zohreh Rahimi
P2860
P356
10.12860/JNP.2015.14
P577
2015-07-01T00:00:00Z